Beam Therapeutics Inc
NASDAQ:BEAM
Income Statement
Earnings Waterfall
Beam Therapeutics Inc
Revenue
|
377.7m
USD
|
Operating Expenses
|
-554.2m
USD
|
Operating Income
|
-176.5m
USD
|
Other Expenses
|
44m
USD
|
Net Income
|
-132.5m
USD
|
Income Statement
Beam Therapeutics Inc
Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||
Revenue |
0
N/A
|
0
+100%
|
0
N/A
|
0
+100%
|
0
N/A
|
0
N/A
|
0
-50%
|
0
+100%
|
0
N/A
|
1
+1 875%
|
52
+6 462%
|
60
+16%
|
77
+28%
|
92
+20%
|
61
-34%
|
77
+26%
|
80
+5%
|
82
+2%
|
378
+363%
|
|
Operating Income | ||||||||||||||||||||
Operating Expenses |
(57)
|
(62)
|
(75)
|
(90)
|
(99)
|
(118)
|
(133)
|
(305)
|
(338)
|
(371)
|
(444)
|
(329)
|
(368)
|
(405)
|
(399)
|
(438)
|
(462)
|
(480)
|
(554)
|
|
Selling, General & Administrative |
(15)
|
(18)
|
(21)
|
(23)
|
(25)
|
(27)
|
(30)
|
(33)
|
(40)
|
(48)
|
(57)
|
(66)
|
(77)
|
(83)
|
(88)
|
(92)
|
(93)
|
(96)
|
(117)
|
|
Research & Development |
(42)
|
(44)
|
(55)
|
(67)
|
(74)
|
(91)
|
(103)
|
(272)
|
(298)
|
(323)
|
(387)
|
(262)
|
(291)
|
(322)
|
(312)
|
(346)
|
(369)
|
(384)
|
(437)
|
|
Operating Income |
(57)
N/A
|
(62)
-9%
|
(75)
-21%
|
(90)
-20%
|
(99)
-10%
|
(118)
-19%
|
(133)
-12%
|
(305)
-130%
|
(337)
-11%
|
(370)
-10%
|
(392)
-6%
|
(268)
+32%
|
(291)
-9%
|
(313)
-7%
|
(338)
-8%
|
(361)
-7%
|
(381)
-6%
|
(398)
-4%
|
(176)
+56%
|
|
Pre-Tax Income | ||||||||||||||||||||
Interest Income Expense |
(12)
|
(8)
|
(3)
|
(5)
|
(12)
|
(9)
|
(62)
|
(61)
|
(69)
|
(41)
|
(1)
|
6
|
33
|
13
|
59
|
56
|
63
|
58
|
36
|
|
Total Other Income |
(59)
|
(6)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
10
|
23
|
24
|
24
|
13
|
19
|
18
|
20
|
27
|
10
|
|
Pre-Tax Income |
(128)
N/A
|
(76)
+41%
|
(78)
-4%
|
(95)
-22%
|
(112)
-17%
|
(127)
-14%
|
(195)
-53%
|
(366)
-88%
|
(408)
-11%
|
(401)
+2%
|
(371)
+8%
|
(238)
+36%
|
(234)
+2%
|
(288)
-23%
|
(260)
+10%
|
(287)
-10%
|
(298)
-4%
|
(313)
-5%
|
(131)
+58%
|
|
Net Income | ||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
0
|
0
|
(1)
|
(1)
|
|
Income from Continuing Operations |
(128)
|
(76)
|
(78)
|
(95)
|
(112)
|
(127)
|
(195)
|
(366)
|
(408)
|
(401)
|
(371)
|
(238)
|
(234)
|
(290)
|
(264)
|
(291)
|
(302)
|
(314)
|
(133)
|
|
Income to Minority Interest |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Equity Earnings Affiliates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(26)
|
(26)
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(134)
N/A
|
(86)
+36%
|
(91)
-6%
|
(106)
-17%
|
(119)
-12%
|
(132)
-10%
|
(196)
-49%
|
(366)
-87%
|
(408)
-11%
|
(401)
+2%
|
(371)
+8%
|
(238)
+36%
|
(234)
+2%
|
(315)
-35%
|
(289)
+8%
|
(316)
-9%
|
(327)
-3%
|
(314)
+4%
|
(133)
+58%
|
|
EPS (Diluted) |
-2.97
N/A
|
-1.91
+36%
|
-2.01
-5%
|
-3.45
-72%
|
-2.41
+30%
|
-2.62
-9%
|
-4.19
-60%
|
-6.07
-45%
|
-6.55
-8%
|
-6.04
+8%
|
-5.77
+4%
|
-3.46
+40%
|
-3.33
+4%
|
-4.48
-35%
|
-4.13
+8%
|
-4.37
-6%
|
-4.28
+2%
|
-3.96
+7%
|
-1.72
+57%
|